joimax® Company Profile

Background

Founded in 2001 and headquartered in Karlsruhe, Germany, joimax® is a global leader in the development and marketing of complete systems for full-endoscopic and minimally invasive spinal surgery. The company's mission is to advance spine care worldwide by delivering cutting-edge technology, continuous innovation, and comprehensive education. joimax® specializes in endoscopic minimally invasive spine surgery, offering solutions that prioritize patient well-being and outcomes.

Key Strategic Focus

joimax® focuses on providing comprehensive endoscopic solutions for spinal surgery procedures, including transforaminal, interlaminar, and cervical approaches. Their product portfolio includes:

TESSYS®: Transforaminal Endoscopic Surgical System for decompression procedures.

iLESSYS®: Interlaminar Endoscopic Surgical System.

CESSYS®: Cervical Endoscopic Surgical System.

MultiZYTE®: For facet and sacroiliac joint pain treatment.

EndoLIF® and Percusys®: For minimally invasive endoscopically assisted stabilizations.

These systems are supported by advanced electronic devices like the NAVENTO® navigated endoscopic tower, enabling surgeons to perform procedures through small incisions under local or full anesthesia, utilizing tissue and muscle-sparing corridors.

Financials and Funding

As a privately held company, joimax® does not publicly disclose detailed financial information. However, the company has demonstrated significant growth, with a compound annual growth rate (CAGR) of 35% since 2008. In 2017, joimax® reported a nearly 30% increase in consolidated sales compared to 2016, with an almost 80% jump in the U.S. market.

Pipeline Development

joimax® continually expands its product offerings to address a wide range of spinal conditions. Notable developments include:

MultiZYTE® Facet and SI Joint Treatment Set: Launched in the U.S. in 2017, this system addresses facet and sacroiliac joint pain.

Endovapor® 2 Multi Radio Frequency System: Approved in China in 2017, this system generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations.

Technological Platform and Innovation

joimax® distinguishes itself through proprietary technologies and innovative methodologies, including:

NAVENTO® Navigated Endoscopic Tower: An advanced system supporting various endoscopic procedures.

Endovapor® 2: A multi-radio frequency system designed for precise tissue cutting and coagulation.

TESSYS®, iLESSYS®, and CESSYS® Systems: Comprehensive surgical solutions for different spinal approaches.

These technologies enable surgeons to perform procedures through small incisions, preserving tissue and muscle, and utilizing natural openings in the spinal canal, such as the intervertebral foramen.

Leadership Team

Maximilian Ries, CEO: Joined joimax® in 2009, serving in various roles before becoming CEO in June 2025. He holds a degree in construction engineering and business administration from VWA in Karlsruhe.

Rainer Schmitz, CFO/COO: With over 40 years of experience in finance and controlling, he has been with joimax® since 2006. He holds a degree in Business Administration and completed further studies at the University of Hagen in Germany.

Wolfgang Ries, Founder & Executive Chairman: Founded joimax® in 2001, bringing over 43 years of professional experience, including 37 years in medical technology. He studied medicine at the University of Vienna and completed various management programs.

Tony Troncale, President of joimax® Inc.: Joined joimax® Inc. in 2021, promoted to General Manager in 2023, and President in 2025. He holds an MBA from UNC, an MHS from Duke University, and a BS in Physiology from UC San Diego.

Leadership Changes

In June 2025, Maximilian Ries was appointed CEO, succeeding his father, Wolfgang Ries, who transitioned to the role of Executive Chairman.

Competitor Profile

Market Insights and Dynamics

The global minimally invasive spine surgery market is experiencing significant growth, driven by advancements in technology, increasing prevalence of spinal disorders, and patient preference for less invasive procedures. joimax® operates in a competitive landscape with several key players.

Competitor Analysis

Maxer: Founded in 2004 and headquartered in Wurmlingen, Germany, Maxer specializes in health care equipment, focusing on endoscopic solutions.

Stryker: Established in 1941 and based in Portage, Michigan, Stryker is a global leader in medical technologies, including spine surgery solutions.

CryoLife: Founded in 1984 in Kennesaw, Georgia, CryoLife operates in the health care equipment industry, offering products related to cardiac and vascular surgery.

Strategic Collaborations and Partnerships

joimax® has established significant partnerships to expand its global presence:

Japan: Partnered with JAPAN MEDICALNEXT CO., LTD. in June 2020 to distribute joimax® products across Japan.

Vietnam: Collaborated with Trang Thi Medical Company Limited in May 2021 to introduce joimax® technologies to the southern provinces of Vietnam, including Da Nang.

Brazil: Partnered with CT Group in 2019 to distribute joimax® products throughout Brazil.

Operational Insights

joimax® differentiates itself through a commitment to innovation, comprehensive training programs, and a focus on minimally invasive techniques that prioritize patient outcomes. The company's global expansion strategy, supported by strategic partnerships, enhances its market position and competitive advantage.